MedPath

Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Registration Number
NCT00002662
Lead Sponsor
Aventis Pharmaceuticals
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether paclitaxel is more effective than docetaxel for breast cancer.

PURPOSE: Randomized phase III trial to study the effectiveness of paclitaxel or docetaxel in treating women with stage IIIB or metastatic breast cancer.

Detailed Description

OBJECTIVES:

* Compare the response rate in women with metastatic or locally advanced, inoperable adenocarcinoma of the breast treated with docetaxel vs paclitaxel.

* Compare the toxicity of these regimens in these patients.

* Compare the time to disease progression, duration of response, quality of life, and survival of patients treated with these regimens.

OUTLINE: This is a randomized, open-label, multicenter study. Patients are randomized to 1 of 2 treatment arms.

* Arm I: Patients receive docetaxel IV over 1 hour on day 1. Courses repeat every 3 weeks in the absence of disease progression or unacceptable toxicity.

* Arm II: Patients receive paclitaxel IV over 3 hours on day 1. Courses repeat every 3 weeks in the absence of disease progression or unacceptable toxicity.

Quality of life is assessed at baseline and after courses 4 and 6.

Patients are followed every 3 months.

PROJECTED ACCRUAL: A total of 400 patients (200 per arm) will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (32)

George Washington University Medical Center

🇺🇸

Washington, District of Columbia, United States

Baptist Regional Cancer Institute - Jacksonville

🇺🇸

Jacksonville, Florida, United States

University of Michigan Comprehensive Cancer Center

🇺🇸

Ann Arbor, Michigan, United States

Medical College of Wisconsin Cancer Center

🇺🇸

Milwaukee, Wisconsin, United States

Georgia Cancer Specialists - DeKalb

🇺🇸

Decatur, Georgia, United States

Blumenthal Cancer Center at Carolinas Medical Center

🇺🇸

Charlotte, North Carolina, United States

Penn State Cancer Institute at Milton S. Hershey Medical Center

🇺🇸

Hershey, Pennsylvania, United States

Roger Williams Medical Center

🇺🇸

Providence, Rhode Island, United States

California Cancer Care, Inc.

🇺🇸

Greenbrae, California, United States

Highlands Oncology Group, P.A. - Fayetteville

🇺🇸

Fayetteville, Arkansas, United States

Green Cancer Center at Scripps Clinic

🇺🇸

La Jolla, California, United States

Mercy Arch Hematology Oncology, P.C.

🇺🇸

Saint Louis, Missouri, United States

Greenville Hospital System

🇺🇸

Greenville, South Carolina, United States

Baptist Regional Cancer Center - Knoxville

🇺🇸

Knoxville, Tennessee, United States

University of Arkansas for Medical Sciences

🇺🇸

Little Rock, Arkansas, United States

James Graham Brown Cancer Center at University of Louisville

🇺🇸

Louisville, Kentucky, United States

Norwich Cancer Center

🇺🇸

Norwich, Connecticut, United States

Maine Center for Cancer Medicine and Blood Disorders - Scarborough

🇺🇸

Scarborough, Maine, United States

Southfield Oncology Institute, Inc.

🇺🇸

Southfield, Michigan, United States

Cleveland Clinic Taussig Cancer Center

🇺🇸

Cleveland, Ohio, United States

Montclair Regional Cancer Center

🇺🇸

Birmingham, Alabama, United States

Sidney Kimmel Cancer Center

🇺🇸

San Diego, California, United States

Northeast Arkansas Clinic

🇺🇸

Jonesboro, Arkansas, United States

Rush-Presbyterian-St. Luke's Medical Center

🇺🇸

Chicago, Illinois, United States

Charles A. Sammons Cancer Center

🇺🇸

Dallas, Texas, United States

University of Texas Health Science Center at San Antonio

🇺🇸

San Antonio, Texas, United States

University of Colorado Cancer Center at University of Colorado Health Sciences Center

🇺🇸

Denver, Colorado, United States

Tufts - New England Medical Center

🇺🇸

Boston, Massachusetts, United States

Charles M. Barrett Cancer Center at University Hospital

🇺🇸

Cincinnati, Ohio, United States

Oncology-Hematology Associates

🇺🇸

Philadelphia, Pennsylvania, United States

Hematology Oncology Consultants Inc

🇺🇸

Columbus, Ohio, United States

Carolinas Hematology-Oncology Associates

🇺🇸

Charlotte, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath